Related Experiment Video
Updated: May 25, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Psychiatric complications of 'Ecstasy' use
Recreational use of Ecstasy (3,4-methylenedioxymethamphetamine) is linked to significant psychiatric disorders. Case studies show prolonged anxiety, depression, and paranoid psychosis following drug ingestion.
Area of Science:
- Neuroscience
- Psychiatry
- Toxicology
Background:
- The recreational drug Ecstasy (3,4-methylenedioxymethamphetamine) is increasingly used.
- Understanding its psychiatric side effects is crucial for public health.
Purpose of the Study:
- To report two cases of significant psychiatric disorders following Ecstasy ingestion.
- To highlight the potential for persistent adverse psychiatric effects.
Main Methods:
- Presentation of two distinct case reports.
- Clinical observation and patient history documentation.
Main Results:
- Case 1: Development of brief paranoid psychosis, recurring and persisting for over a month after a second dose.
- Case 2: Persistent symptoms of anxiety and depression lasting more than 8 weeks post-ingestion.
Conclusions:
- Ecstasy (3,4-methylenedioxymethamphetamine) use can precipitate serious and prolonged psychiatric disturbances.
- These findings underscore the potential neurotoxicity and psychiatric risks associated with recreational Ecstasy use.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Related Concept Videos
CNS Stimulants: Psychedelic Agents
Hallucinogens and Psychedelics
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains delta-9-tetrahydrocannabinol (THC)...
Electroconvulsive Therapy
Toxidromes: Clinical Features
Psychosis and Antipsychotic Drugs: Overview
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids